MINNEAPOLIS--(BUSINESS WIRE)--Seeking to address a challenge facing interventional cardiologists and hundreds of thousands of patients with coronary artery disease worldwide, Medtronic, Inc. (NYSE: MDT), announced today the first human use of its investigational bifurcation stent. The new stent employs an innovative Y-shaped design to match the anatomy of lesions that form at the junctions of coronary arteries.
